Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacteol in diarrhea-predominant irritable bowel syndrome
NCT01358708Phase 3Terminated
- Sponsor
- Forest Laboratories
- Start
- Jun 2010
- Primary completion
- Sep 2011
- Modality
- Microbiome Therapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Lactobacillus LB in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Forest Laboratories. Started Jun 2010; status: terminated.
02
Drugs
Lactobacillus LB
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01358708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358708.